论文部分内容阅读
目的探讨阿托伐他汀联合通心络胶囊治疗冠心病的临床效果。方法选择我院住院治疗的冠心病患者84例,随机分成治疗组和对照组,每组各42例。对照组应用阿托伐他汀治疗,治疗组应用阿托伐他汀联合通心络胶囊治疗,对比观察两组患者血脂水平、临床疗效及不良反应情况。结果两组患者TC、TG、LDL-C水平治疗前后相比,差异有统计学意义(P<0.05),治疗后治疗组TC、TG、LDL-C水平治疗组明显低于对照组,差异有统计学意义(P<0.05)。治疗组总有效率高于对照组,差异有统计学意义(P<0.05)。两组不良反应率比较,差异无统计学意义(P>0.05)。结论阿托伐他汀联合通心络胶囊能有效调节患者血脂水平,无严重不良反应,可有效治疗冠心病。
Objective To investigate the clinical effect of atorvastatin combined with Tongxinluo capsule in the treatment of coronary heart disease. Methods 84 patients with coronary heart disease hospitalized in our hospital were randomly divided into treatment group and control group, 42 cases in each group. The control group was treated with atorvastatin. The treatment group was treated with atorvastatin combined with Tongxinluo capsule. The blood lipid level, clinical efficacy and adverse reactions of the two groups were compared. Results The levels of TC, TG and LDL-C in the two groups had significant difference before and after treatment (P <0.05). The levels of TC, TG and LDL-C in the treatment group were significantly lower than those in the control group after treatment Statistical significance (P <0.05). The total effective rate of the treatment group was higher than that of the control group, the difference was statistically significant (P <0.05). Adverse reactions between the two groups, the difference was not statistically significant (P> 0.05). Conclusion Atorvastatin combined with Tongxinluo Capsule can effectively regulate the level of blood lipids in patients without serious adverse reactions and can effectively treat coronary heart disease.